The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

P. Glorius; A. Baerenwaldt; C. Kellner; M. Staudinger; M. Dechant; M. Stauch; F.J. Beurskens; P.W.H.I. Parren; J.G.J. van de Winkel; T. Valerius; A. Humpe; R. Repp; M. Gramatzki; F. Nimmerjahn; M. Peipp

doi:10.1038/leu.2012.150

The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

P. Glorius, A. Baerenwaldt, C. Kellner, M. Staudinger, M. Dechant, M. Stauch, F.J. Beurskens, P.W.H.I. Parren, J.G.J. van de Winkel, T. Valerius, A. Humpe, R. Repp, M. Gramatzki, F. Nimmerjahn, M. Peipp

Center for Translational Immunology (CTI)

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	190-201
Number of pages	12
Journal	Leukemia
Volume	27
Issue number	1
DOIs	https://doi.org/10.1038/leu.2012.150
Publication status	Published - 2013

Access to Document

10.1038/leu.2012.150

http://www.ncbi.nlm.nih.gov/pubmed/22660187

Cite this

Glorius, P., Baerenwaldt, A., Kellner, C., Staudinger, M., Dechant, M., Stauch, M., Beurskens, F. J., Parren, P. W. H. I., van de Winkel, J. G. J., Valerius, T., Humpe, A., Repp, R., Gramatzki, M., Nimmerjahn, F., & Peipp, M. (2013). The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells. Leukemia, 27(1), 190-201. https://doi.org/10.1038/leu.2012.150

@article{00094748c95c46ebaa6dba76ded673fe,

title = "The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.",

author = "P. Glorius and A. Baerenwaldt and C. Kellner and M. Staudinger and M. Dechant and M. Stauch and F.J. Beurskens and P.W.H.I. Parren and {van de Winkel}, J.G.J. and T. Valerius and A. Humpe and R. Repp and M. Gramatzki and F. Nimmerjahn and M. Peipp",

year = "2013",

doi = "10.1038/leu.2012.150",

language = "English",

volume = "27",

pages = "190--201",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

Glorius, P, Baerenwaldt, A, Kellner, C, Staudinger, M, Dechant, M, Stauch, M, Beurskens, FJ, Parren, PWHI, van de Winkel, JGJ, Valerius, T, Humpe, A, Repp, R, Gramatzki, M, Nimmerjahn, F & Peipp, M 2013, 'The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.', Leukemia, vol. 27, no. 1, pp. 190-201. https://doi.org/10.1038/leu.2012.150

TY - JOUR

T1 - The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

AU - Glorius, P.

AU - Baerenwaldt, A.

AU - Kellner, C.

AU - Staudinger, M.

AU - Dechant, M.

AU - Stauch, M.

AU - Beurskens, F.J.

AU - Parren, P.W.H.I.

AU - van de Winkel, J.G.J.

AU - Valerius, T.

AU - Humpe, A.

AU - Repp, R.

AU - Gramatzki, M.

AU - Nimmerjahn, F.

AU - Peipp, M.

PY - 2013

Y1 - 2013

U2 - 10.1038/leu.2012.150

DO - 10.1038/leu.2012.150

M3 - Article

C2 - 22660187

SN - 0887-6924

VL - 27

SP - 190

EP - 201

JO - Leukemia

JF - Leukemia

IS - 1

ER -